GSK Says Asia Pacific Sales Could Double
GlaxoSmithKline said its Asia Pacific sales could double in the next five years as growing wealth boosts demands for better healthcare and as it cuts prices in some Asian countries. "Clearly there will be a very high demand in the future because the economic development of the countries in the region and people want more healthcare," Christophe Weber, GSK Asia Pacific chief, told Reuters. [more...]
|
|
|
